戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              CDR1 accumulates in intercellular fluid in response to p
2                                              CDR1 disruption had a partial effect, reducing fluconazo
3                                              CDR1 elements of both subunits of NITR dimers form ligan
4                                              CDR1, which directly interacted with adaptor protein 1 (
5 , cerebellar degeneration related protein 1 (CDR1).
6 ncoded complementarity determining region 1 (CDR1) and CDR2 of the V alpha element can be responsible
7 nts in complementarity-determining region 1 (CDR1) and CDR2, and less than two replacements in the fr
8 ted in complementarity-determining region 1 (CDR1) and CDR2, which exhibited higher replacement-to-si
9  chain complementarity determining region 1 (CDR1) of a humanized IgG1 monoclonal antibody.
10  30 in complementarity-determining region 1 (CDR1) of the TCR alpha-chain interacts with the I-A alph
11 ate in complementarity determining region 1 (CDR1) on zero, one, and two light chain arms.
12 er the complementarity-determining region 1 (CDR1) or CDR2 were sufficient to change selection from t
13  which complementarity-determining region 1 (CDR1), CDR2, and framework region 3 (FR3) are predicted
14 s 44-52, and one patient also responded to a CDR1 peptide.
15              We hypothesize that the V alpha CDR1 region recognizes NH2-terminal PFRs, while the V be
16 ormation of disulfide bonds between CDR3 and CDR1, FW2, or CDR2 was also observed, as described in ca
17  significantly inhibited LUSC metastases and CDR1 was sufficient to promote migration and metastases.
18 of CDR1 generates a small mobile signal, and CDR1 action is blocked by the protease inhibitor pepstat
19                                    Antisense CDR1 plants were compromised for resistance to avirulent
20 ts, the intrinsic probability of mutation at CDR1 can be almost twice that of CDR3.
21 cognizes NH2-terminal PFRs, while the V beta CDR1 region recognizes COOH-terminal PFRs.
22 termining region of the TcR beta chain (beta:CDR1) points outward and interacts with highly conserved
23 id-dependent cooperative interaction between CDR1 and CDR3 residues that are separated by more than 9
24 th studies revealed that the antigen-binding CDR1 loop is the least protected part in the variable do
25         The epitope was recognized mainly by CDR1 and CDR2 of the heavy chain, which are highly conse
26   Movements of the CD8alpha CDR2 and CD8beta CDR1 and CDR2 loops as well as the flexibility of the H-
27         Therapeutic inhibition of the CDR1as/CDR1 axis with miR-671-5p mimics reduced metastasis in v
28 an residues including one in the heavy chain CDR1 and a tryptophan in close proximity to heavy chain
29 g to the anti-Id were located in heavy chain CDR1 and CDR2 and were peripheral to the residues within
30 geting non-germline hot spots in heavy chain CDR1 and CDR3 were generated but did not produce Fv with
31 ining region (CDR3) (H3) and its light chain CDR1 (L1) are closely associated.
32 human mAb; a large insert in the light chain CDR1 of mAb SN66E3 distinguished it from both CRll-351 a
33 ong HCDR3, and a deletion in the light chain CDR1.
34  interactions between the DRVIA7 light-chain CDR1 and the N terminus with N276 and V5 glycans of gp12
35 gnition was still dependent on the conserved CDR1/CDR2 residues.
36  16 microg ml(-1)) similarly show coordinate CDR1-PDH1 upregulation, and in one of these (F15) a puta
37  two parts of the CDR region here designated CDR1 and CDR2 (closest to the carboxyl end) each consist
38 ugs and express the drug efflux determinants CDR1, CDR2 and MDR1.
39 hese anti-DKK1 antibody leads targeting DKK1 CDR1 are potent in inhibition of tumor growth and may ha
40       We also tried engrafting the elongated CDR1 of the heavy chain from bNAb 1-18, another highly p
41 ity during Ag recognition while gene-encoded CDR1 and CDR2 contribute to the fine specificity of the
42    Within this hotspot, key germline-encoded CDR1 and CDR2 loop residues and a crucial but commonly c
43  transition state using the germline-encoded CDR1 and CDR2 loops.
44 and antibodies, whereas the germline-encoded CDR1 and CDR2 sequences are much more cross-reactive.
45 DR) loops that are either germ line-encoded (CDR1 and CDR2) or somatically rearranged (CDR3).
46 tified key positions in the VH gene encoding CDR1, CDR2, and the immunoglobulin framework that are cr
47      We found that the mRNA levels of ERG11, CDR1, CDR2, and MDR1, the candidate fluconazole resistan
48 2) of the beta-chain and, to lesser extents, CDR1 and hypervariable region 4 (HV4), bind in a cleft b
49                                        A few CDR1 and CDR2 amino acids dominated the most crossreacti
50  extends the database of canonical forms for CDR1 and CDR2, and has implications for antigen recognit
51  have explored the sequence requirements for CDR1 and CDR2 of the TCR alpha-chain in a human T cell r
52    This report demonstrates a novel role for CDR1 in promoting metastasis and Golgi trafficking.
53  chain variable region, including framework, CDR1, and CDR2 mutations.
54                        Peptides derived from CDR1 of 44aacb, CDR2 of 118.1, and CDRs 1 and 3 of MY904
55 rexpression of the efflux pump encoding gene CDR1 (4-fold).
56                Evaluation of candidate genes CDR1 and SOX3 did not reveal mutations in affected male
57 ed expression of multidrug transporter genes CDR1 and PDH1.
58                    However, mutagenesis of H:CDR1 did not result in such a specificity change despite
59 ficity change despite the proximity of the H:CDR1 hapten contact residue Asn-35 to the cardenolide 16
60  resistance of a cka2 mutant, as expected if CDR1 and CDR2 overexpression is responsible for fluconaz
61          Finally, we show that residue 29 in CDR1 of the TCR beta-chain affects recognition of the gl
62 n requirements for particular side chains in CDR1 and CDR2 and in their relative binding contribution
63        Replacing the overlapping hotspots in CDR1 and CDR2 with neutral or cold motifs resulted in a
64  among the VH and VL segments are located in CDR1 and -3.
65                            Asp27d present in CDR1 formed hydrogen bonds with the side-chain and main-
66 so, when another carbohydrate was present in CDR1, CDR2, or CDR3 of the L chain, the V(H) CDR2 glycan
67 B:9-23 or that of two amino acid residues in CDR1 and 2 of the TRAV5D-4.
68           Mutational analysis of residues in CDR1 and CDR2 of the three Valpha2 regions showed the im
69  TCRs show that germline-encoded residues in CDR1 and CDR3 regions of TRBV4-1-encoded sequences inter
70 four putative solvent-accessible residues in CDR1 to A, D, S, or Y.
71 ant bias toward replacement substitutions in CDR1; in Tm clones there was no significant bias toward
72 ctedly, every TCR mutant, including those in CDR1 and CDR2, retained remarkable peptide specificity.
73 ed both constitutive and fluconazole-induced CDR1-PDH1 expression.
74 he catalytic subunits to CipA which involves CDR1, an IRE, and calcium.
75                       Two mutations, D32H (L-CDR1) and E1K (L-FR1) altered the electrostatic surface
76 ng GD2 affinity, the double mutation D32H (L-CDR1) and E1K (L-FR1) did not further improve anti-tumor
77 t in affinity of hu3F8 with a single D32H (L-CDR1) mutation translated into a approximately 12-fold i
78 lonally restricted autoantigen, with minimal CDR1, CDR2, or HV4 contributions.
79 to block proliferation, with the activity of CDR1 > CDR2 > CDR4.
80                              Combinations of CDR1 peptide with CDR2 or CDR4 peptides allosterically e
81 stricted TCR, including the conformations of CDR1 and 2.
82 indicates that transient gene duplication of CDR1 and ERG11 causes the observed age-dependent enhance
83  is flipped into a cavity formed by Gly35 of CDR1, thereby increasing the hydrophilicity of the V(H):
84                                 Induction of CDR1 generates a small mobile signal, and CDR1 action is
85 studies revealed transient overexpression of CDR1 and ERG11 mRNA in the presence of fluconazole that
86 2T increased the amyloidogenic propensity of CDR1 loop, decreased its protection in the native struct
87 he PPR and B2542 strains, the replacement of CDR1 of fCD134 (amino acids 1 to 64) with human CD134 (h
88                 Finally, alanine scanning of CDR1 and CDR2 sequences of TRBV4-1 revealed two unique r
89 tides containing the amino acid sequences of CDR1 and CDR2 (designated bCDR1 and bCDR2) were synthesi
90                       Silencing of CDR1as or CDR1 significantly inhibited LUSC metastases and CDR1 wa
91                     cka2 mutants overexpress CDR1 and CDR2, two fluconazole efflux transporter genes,
92 ases through a previously unstudied protein, CDR1.
93                Two fluconazole efflux pumps, CDR1 and CDR2, were upregulated in the in vivo biofilm-a
94 uted at the peptidic termini at the putative CDR1 contact regions show improved recognition in B6 mic
95 est that some amino acids in variable region CDR1 and CDR2s almost always react in a consistent way w
96 uence, the complementary determining regions CDR1 and CDR3 of the TCR Valpha and Vbeta domains make t
97 ermline complementarity determining regions (CDR1 and 2) in MHC restriction is not well understood.
98  second complementarity determining regions (CDR1 and CDR2) of this Valpha are shorter than the CDRs
99 s three complementarity-determining regions (CDR1-CDR3), which contribute to antigen specificity.
100  identified constitutive disease resistance (CDR1) encoding an apoplastic aspartic protease, the over
101 diverse peptides, and moderately diverse TCR CDR1 and CDR2 regions contact moderately diverse MHC alp
102 -MHC (pMHC) was mainly recognized by the TCR CDR1 and CDR2 loops in an MHC-centric manner.
103  to the high amino acid diversity of the TCR CDR1 and CDR2 loops, and that such conservation is unlik
104         In contrast, it has been argued that CDR1 and CDR2 are involved to a greater extent than CDR3
105                              We propose that CDR1 mediates a peptide signal system involved in the ac
106 he TCRs in complex with QL9-L(d) showed that CDR1, CDR2, and CDR3beta conformations and docking orien
107                     The results suggest that CDR1 is critical in amyloid formation by other 6 LCs.
108                                          The CDR1 and CDR2 therefore represent new canonical forms th
109                                          The CDR1, CDR2 and CDR4 peptides were each able to block pro
110 ntify a fibrillogenic hotspot located at the CDR1 and beta-strand C of the protein, which was confirm
111 of a VL, domain, which terminates before the CDR1 region.
112 unit(s) in the heterodimer or homodimer, the CDR1 loop of CD8beta tilts away from its corresponding C
113                         The sequences in the CDR1 alpha and CDR2 alpha correlate with differential ex
114        This study shows that residues in the CDR1 and CDR2 regions are primary determinants for MHC c
115  identified and implies that residues in the CDR1 and CDR2-equivalent loops of CD8beta are occluded u
116                   Other substitutions in the CDR1 loop and mutations spanning the CDR2 and DE loops h
117 hat alanine substitutions of residues in the CDR1 loop of CD8beta have no effect on CD8alphabeta core
118 rangement by aspartic acid residue 31 in the CDR1 on the light chain.
119           If the overlapping hotspots in the CDR1 or CDR2 did not undergo mutation, the frequency of
120 ally, 8 of 9 of these events occurred in the CDR1 or CDR2, following a pattern consistent with select
121 beta mutants and identified mutations in the CDR1, CDR2, and CDR3 loops that decreased binding to MHC
122 e conservative F substitution of Y 26 in the CDR1-like region also reduced binding to CD80 and CD86.
123  share a lysine to glutamate mutation in the CDR1.
124 nment of the V region, and especially of the CDR1 and CDR2, is highly evolved to recruit mutations to
125 gs are inconsistent with the notion that the CDR1 and CDR2 loops of the TCR are responsible for MHC r
126                         We conclude that the CDR1 and CDR3 regions contribute to a common binding sit
127 all conformational changes, localized to the CDR1 contact regions, may play a significant role in TCR
128 at a fibrillogenic hotspot associated to the CDR1 is also encoded by several kappa and lambda germlin
129  of homologous peptides corresponding to the CDR1 segments of human Vbeta gene products, a major epit
130 ay play a role through interactions with the CDR1.
131 erminal of the MYPPPY region, and within the CDR1-like region of CTLA-4, eliminated both CD80 and CD8
132 icking through its complimentary transcript, CDR1.
133 and neonate in the first 6 weeks have unique CDR1 and CDR2 sequences, permitting each to be identifie
134 owever, so-called "hybrid" VH genes that use CDR1 of one VH gene and the CDR2 of another are frequent
135 en interacts with some portion of the Valpha CDR1 or CDR2 region.
136 utations in the first residue of the Valpha, CDR1, CDR2, or CDR3 were isolated.
137 volutionarily selected germline Valpha/Vbeta CDR1/CDR2 loops to create highly MHC/peptide cross-react
138       In the current studies, such CDRs were CDR1 of the heavy chain (H1) and CDR2 of the light chain
139 , RSB1, RPN4, YLR346c and YMR102c along with CDR1, PDH1 and PDR1 itself) or downregulated (PDR12); ro
140 lementarity-determining regions (CDRs), with CDR1 and CDR2 encoded by the V segment and CDR3 encoded
141  exclusively bearing VDJ rearrangements with CDR1, CDR2, and nearly intact DH segments in germline co
142 a germline hot spot (Ser(30)-Asn(31)) within CDR1 of the antibody light chain was mutated.
143 a specific asparagine residue located within CDR1 and occurs with complete loss of CDR2.

 
Page Top